Annual Total Debt
$179.63 M
+$22.15 M+14.07%
31 December 2023
Summary:
Heron Therapeutics annual total debt is currently $179.63 million, with the most recent change of +$22.15 million (+14.07%) on 31 December 2023. During the last 3 years, it has risen by +$155.02 million (+629.87%). HRTX annual total debt is now at all-time high.HRTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$178.25 M
-$466.00 K-0.26%
30 September 2024
Summary:
Heron Therapeutics quarterly total debt is currently $178.25 million, with the most recent change of -$466.00 thousand (-0.26%) on 30 September 2024. Over the past year, it has dropped by -$1.75 million (-0.97%). HRTX quarterly total debt is now -0.97% below its all-time high of $180.00 million, reached on 30 September 2023.HRTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.1% | -1.0% |
| 3 y3 years | +629.9% | +8.4% |
| 5 y5 years | +3827.2% | +898.1% |
HRTX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +629.9% | -1.0% | +14.2% |
| 5 y | 5 years | at high | +3827.2% | -1.0% | +898.1% |
| alltime | all time | at high | -1.0% |
Heron Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $178.25 M(-0.3%) |
| June 2024 | - | $178.71 M(-0.3%) |
| Mar 2024 | - | $179.17 M(-0.3%) |
| Dec 2023 | $179.63 M(+14.1%) | $179.63 M(-0.2%) |
| Sept 2023 | - | $180.00 M(+15.3%) |
| June 2023 | - | $156.13 M(-0.5%) |
| Mar 2023 | - | $156.93 M(-0.3%) |
| Dec 2022 | $157.48 M(-1.3%) | $157.48 M(-0.3%) |
| Sept 2022 | - | $158.00 M(-0.3%) |
| June 2022 | - | $158.51 M(-0.3%) |
| Mar 2022 | - | $159.01 M(-0.3%) |
| Dec 2021 | $159.50 M(+548.1%) | $159.50 M(-3.0%) |
| Sept 2021 | - | $164.50 M(-0.4%) |
| June 2021 | - | $165.16 M(+576.2%) |
| Mar 2021 | - | $24.43 M(-0.8%) |
| Dec 2020 | $24.61 M(+24.3%) | $24.61 M(-0.9%) |
| Sept 2020 | - | $24.85 M(-1.1%) |
| June 2020 | - | $25.11 M(-1.1%) |
| Mar 2020 | - | $25.40 M(+28.3%) |
| Dec 2019 | $19.79 M(+332.7%) | $19.79 M(+10.8%) |
| Sept 2019 | - | $17.86 M(-1.1%) |
| June 2019 | - | $18.05 M(-2.8%) |
| Mar 2019 | - | $18.58 M(+306.1%) |
| Dec 2018 | $4.57 M(-84.1%) | $4.57 M(+5.4%) |
| Sept 2018 | - | $4.34 M(-85.1%) |
| June 2018 | - | $29.11 M(+0.8%) |
| Mar 2018 | - | $28.89 M(+0.7%) |
| Dec 2017 | $28.68 M(-45.8%) | $28.68 M(+0.7%) |
| Sept 2017 | - | $28.48 M(+0.7%) |
| June 2017 | - | $28.29 M(-46.7%) |
| Mar 2017 | - | $53.10 M(+0.3%) |
| Dec 2016 | $52.91 M(+2281.2%) | $52.91 M(+0.3%) |
| Sept 2016 | - | $52.73 M(+1961.5%) |
| June 2016 | - | $2.56 M(+7.1%) |
| Mar 2016 | - | $2.39 M(+7.5%) |
| Dec 2015 | $2.22 M(+39.0%) | $2.22 M(+7.8%) |
| Sept 2015 | - | $2.06 M(+8.3%) |
| June 2015 | - | $1.90 M(+8.8%) |
| Mar 2015 | - | $1.75 M(+9.4%) |
| Dec 2014 | $1.60 M(+55.9%) | $1.60 M(+10.2%) |
| Sept 2014 | - | $1.45 M(+11.0%) |
| June 2014 | - | $1.31 M(+12.2%) |
| Mar 2014 | - | $1.16 M(+13.6%) |
| Dec 2013 | $1.02 M(+108.3%) | $1.02 M(+15.4%) |
| Sept 2013 | - | $888.00 K(+17.8%) |
| June 2013 | - | $754.00 K(+21.2%) |
| Mar 2013 | - | $622.00 K(+26.4%) |
| Dec 2012 | $492.00 K(+377.7%) | $492.00 K(>+9900.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(-100.0%) |
| Dec 2011 | $103.00 K(>+9900.0%) | $103.00 K(+60.9%) |
| Sept 2011 | - | $64.00 K(+156.0%) |
| June 2011 | - | $25.00 K(>+9900.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2008 | - | $0.00(0.0%) |
| June 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2007 | - | $0.00(0.0%) |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2000 | - | $0.00(-100.0%) |
| June 2000 | - | $2.87 M(-7.1%) |
| Mar 2000 | - | $3.09 M(-6.4%) |
| Dec 1999 | $3.30 M(+6.5%) | $3.30 M(-15.4%) |
| Sept 1999 | - | $3.90 M(+2.6%) |
| June 1999 | - | $3.80 M(-11.6%) |
| Mar 1999 | - | $4.30 M(+38.7%) |
| Dec 1998 | $3.10 M(-44.6%) | $3.10 M(-16.2%) |
| Sept 1998 | - | $3.70 M(-14.0%) |
| June 1998 | - | $4.30 M(-14.0%) |
| Mar 1998 | - | $5.00 M(-10.7%) |
| Dec 1997 | $5.60 M(-21.1%) | $5.60 M(-9.7%) |
| Sept 1997 | - | $6.20 M(-4.6%) |
| June 1997 | - | $6.50 M(-4.4%) |
| Mar 1997 | - | $6.80 M(-4.2%) |
| Dec 1996 | $7.10 M(-2.7%) | $7.10 M(-20.2%) |
| Sept 1996 | - | $8.90 M(+8.5%) |
| June 1996 | - | $8.20 M(+6.5%) |
| Mar 1996 | - | $7.70 M(+5.5%) |
| Dec 1995 | $7.30 M(+128.1%) | $7.30 M(+19.7%) |
| Sept 1995 | - | $6.10 M(+110.3%) |
| June 1995 | - | $2.90 M(-6.5%) |
| Mar 1995 | - | $3.10 M(-3.1%) |
| Dec 1994 | $3.20 M(-13.5%) | $3.20 M(-5.9%) |
| Sept 1994 | - | $3.40 M(0.0%) |
| June 1994 | - | $3.40 M(-5.6%) |
| Mar 1994 | - | $3.60 M(-2.7%) |
| Dec 1993 | $3.70 M(-7.5%) | $3.70 M(-2.6%) |
| Sept 1993 | - | $3.80 M(-2.6%) |
| June 1993 | - | $3.90 M(0.0%) |
| Mar 1993 | - | $3.90 M(-2.5%) |
| Dec 1992 | $4.00 M(0.0%) | $4.00 M(0.0%) |
| Sept 1992 | - | $4.00 M(0.0%) |
| June 1992 | - | $4.00 M(0.0%) |
| Mar 1992 | - | $4.00 M(0.0%) |
| Dec 1991 | $4.00 M(+33.3%) | $4.00 M(+33.3%) |
| Sept 1991 | - | $3.00 M(0.0%) |
| June 1991 | - | $3.00 M(0.0%) |
| Mar 1991 | - | $3.00 M(0.0%) |
| Dec 1990 | $3.00 M(0.0%) | $3.00 M(0.0%) |
| Sept 1990 | - | $3.00 M(0.0%) |
| June 1990 | - | $3.00 M(0.0%) |
| Mar 1990 | - | $3.00 M(0.0%) |
| Dec 1989 | $3.00 M(0.0%) | $3.00 M(0.0%) |
| Sept 1989 | - | $3.00 M(0.0%) |
| June 1989 | - | $3.00 M(>+9900.0%) |
| Mar 1989 | - | $0.00(-100.0%) |
| Dec 1988 | $3.00 M(-6.3%) | $3.00 M(>+9900.0%) |
| Sept 1988 | - | $0.00(0.0%) |
| June 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(-100.0%) |
| Dec 1987 | $3.20 M | $3.20 M(>+9900.0%) |
| Sept 1987 | - | $0.00(0.0%) |
| June 1987 | - | $0.00(0.0%) |
| Mar 1987 | - | $0.00 |
FAQ
- What is Heron Therapeutics annual total debt?
- What is the all time high annual total debt for Heron Therapeutics?
- What is Heron Therapeutics annual total debt year-on-year change?
- What is Heron Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Heron Therapeutics?
- What is Heron Therapeutics quarterly total debt year-on-year change?
What is Heron Therapeutics annual total debt?
The current annual total debt of HRTX is $179.63 M
What is the all time high annual total debt for Heron Therapeutics?
Heron Therapeutics all-time high annual total debt is $179.63 M
What is Heron Therapeutics annual total debt year-on-year change?
Over the past year, HRTX annual total debt has changed by +$22.15 M (+14.07%)
What is Heron Therapeutics quarterly total debt?
The current quarterly total debt of HRTX is $178.25 M
What is the all time high quarterly total debt for Heron Therapeutics?
Heron Therapeutics all-time high quarterly total debt is $180.00 M
What is Heron Therapeutics quarterly total debt year-on-year change?
Over the past year, HRTX quarterly total debt has changed by -$1.75 M (-0.97%)